Healthcare provider profile · identity verified

Kenneth Ronald Smith, MD

Internal Medicine · BRIDGEVILLE, DE · NPI 1316029077

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	877	232
Levothyroxine Sodium	Levothyroxine Sodium	645	153
Amlodipine Besylate	Amlodipine Besylate	516	128
Losartan Potassium	Losartan Potassium	495	128
Omeprazole	Omeprazole	462	112
Meloxicam	Meloxicam	438	119
Lisinopril	Lisinopril	405	99
Simvastatin	Simvastatin	332	74
Glipizide Er	Glipizide	303	73
Hydrochlorothiazide	Hydrochlorothiazide	293	80
Gabapentin	Gabapentin	284	68
Metoprolol Succinate	Metoprolol Succinate	280	71
Pantoprazole Sodium	Pantoprazole Sodium	269	69
Furosemide	Furosemide	250	66
Metformin Hcl	Metformin Hcl	243	67
Tizanidine Hcl	Tizanidine Hcl	232	77
Tamsulosin Hcl	Tamsulosin Hcl	216	61
Escitalopram Oxalate	Escitalopram Oxalate	178	48
Clopidogrel	Clopidogrel Bisulfate	175	43
Tramadol Hcl	Tramadol Hcl	162	21
Pravastatin Sodium	Pravastatin Sodium	160	39
Albuterol Sulfate Hfa	Albuterol Sulfate	159	45
Fluticasone Propionate	Fluticasone Propionate	158	45
Eliquis	Apixaban	137	46
Jardiance	Empagliflozin	131	30
Sertraline Hcl	Sertraline Hcl	131	33
Rosuvastatin Calcium	Rosuvastatin Calcium	129	40
Celecoxib	Celecoxib	122	32
Montelukast Sodium	Montelukast Sodium	117	35
Ropinirole Hcl	Ropinirole Hcl	115	26
Bisoprolol Fumarate	Bisoprolol Fumarate	109	30
Allopurinol	Allopurinol	107	26
Synthroid	Levothyroxine Sodium	106	30
Carvedilol	Carvedilol	104	27
Zolpidem Tartrate	Zolpidem Tartrate	100	16
Farxiga	Dapagliflozin Propanediol	99	24
Metoprolol Tartrate	Metoprolol Tartrate	92	24
Ipratropium Bromide	Ipratropium Bromide	85	45
Meclizine Hcl	Meclizine Hcl	79	25
Levofloxacin	Levofloxacin	78	59
Finasteride	Finasteride	77	21
Prednisone	Prednisone	77	42
Potassium Chloride	Potassium Chloride	76	19
Famotidine	Famotidine	72	18
Doxazosin Mesylate	Doxazosin Mesylate	68	19
Lovastatin	Lovastatin	66	15
Glipizide	Glipizide	64	16
Trazodone Hcl	Trazodone Hcl	62	14
Ciprofloxacin Hcl	Ciprofloxacin Hcl	61	51
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	58	14
Cefdinir	Cefdinir	57	49
Citalopram Hbr	Citalopram Hydrobromide	56	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	56	14
Alprazolam	Alprazolam	53	suppressed
Hydralazine Hcl	Hydralazine Hcl	53	suppressed
Atenolol	Atenolol	52	16
Ozempic	Semaglutide	52	12
Doxycycline Hyclate	Doxycycline Hyclate	51	42
Lorazepam	Lorazepam	49	suppressed
Warfarin Sodium	Warfarin Sodium	49	11
Esomeprazole Magnesium	Esomeprazole Magnesium	48	suppressed
Ibuprofen	Ibuprofen	47	18
Isosorbide Mononitrate Er	Isosorbide Mononitrate	46	13
Propranolol Hcl	Propranolol Hcl	45	11
Januvia	Sitagliptin Phosphate	43	suppressed
Diazepam	Diazepam	42	suppressed
Cephalexin	Cephalexin	40	30
Duloxetine Hcl	Duloxetine Hcl	40	11
Ondansetron Odt	Ondansetron	40	16
Paxlovid	Nirmatrelvir/Ritonavir	40	40
Wixela Inhub	Fluticasone Propion/Salmeterol	40	suppressed
Ezetimibe	Ezetimibe	39	11
Fenofibrate	Fenofibrate Nanocrystallized	38	11
Glimepiride	Glimepiride	36	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	36	27
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	35	suppressed
Primidone	Primidone	35	suppressed
Spironolactone	Spironolactone	35	suppressed
Benazepril Hcl	Benazepril Hcl	34	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	34	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	33	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	32	suppressed
Felodipine Er	Felodipine	31	suppressed
Ventolin Hfa	Albuterol Sulfate	31	suppressed
Amiodarone Hcl	Amiodarone Hcl	30	suppressed
Clonazepam	Clonazepam	30	suppressed
Amoxicillin	Amoxicillin	29	21
Venlafaxine Hcl Er	Venlafaxine Hcl	29	suppressed
Azithromycin	Azithromycin	28	22
Nifedipine Er	Nifedipine	28	suppressed
Tradjenta	Linagliptin	28	suppressed
Paroxetine Hcl	Paroxetine Hcl	27	suppressed
Digoxin	Digoxin	26	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	26	suppressed
Tresiba Flextouch U-200	Insulin Degludec	26	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	25	suppressed
Valsartan	Valsartan	25	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	24	suppressed
Symbicort	Budesonide/Formoterol Fumarate	24	suppressed
Buspirone Hcl	Buspirone Hcl	23	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Bupropion Xl	Bupropion Hcl	22	suppressed
Fluconazole	Fluconazole	22	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	22	suppressed
Verapamil Er	Verapamil Hcl	22	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	21	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	21	suppressed
Nystatin	Nystatin	21	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	21	13
Zolpidem Tartrate Er	Zolpidem Tartrate	21	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	20	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	20	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	19	suppressed
Nitroglycerin	Nitroglycerin	19	12
Breyna	Budesonide/Formoterol Fumarate	18	suppressed
Bupropion Hcl Sr	Bupropion Hcl	18	suppressed
Clindamycin Hcl	Clindamycin Hcl	18	14
Metronidazole	Metronidazole	18	11
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	18	suppressed
Alendronate Sodium	Alendronate Sodium	17	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	17	suppressed
Lamotrigine	Lamotrigine	17	suppressed
Ramipril	Ramipril	17	suppressed
Solifenacin Succinate	Solifenacin Succinate	17	suppressed
Terazosin Hcl	Terazosin Hcl	17	suppressed
Doxepin Hcl	Doxepin Hcl	16	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	16	suppressed
Trulicity	Dulaglutide	16	suppressed
Xarelto	Rivaroxaban	16	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	15	suppressed
Carisoprodol	Carisoprodol	15	suppressed
Clonidine Hcl	Clonidine Hcl	15	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	15	suppressed
Ketoconazole	Ketoconazole	15	12
Metformin Hcl Er	Metformin Hcl	15	suppressed
Mupirocin	Mupirocin	15	11
Pioglitazone Hcl	Pioglitazone Hcl	15	suppressed
Propranolol Hcl Er	Propranolol Hcl	15	suppressed
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	15	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	15	suppressed
Dutasteride	Dutasteride	14	suppressed
Humalog Kwikpen U-100	Insulin Lispro	14	suppressed
Naproxen	Naproxen	14	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	14	suppressed
Colchicine	Colchicine	13	suppressed
Desmopressin Acetate	Desmopressin Acetate	13	suppressed
Dexlansoprazole Dr	Dexlansoprazole	13	suppressed
Midodrine Hcl	Midodrine Hcl	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	13	suppressed
Invokana	Canagliflozin	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Mycophenolate Mofetil	Mycophenolate Mofetil	12	suppressed
Testosterone	Testosterone	12	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	11	suppressed
Arthrotec 75	Diclofenac Sodium/Misoprostol	11	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	11	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	11	suppressed
Diltiazem 24hr Er (La)	Diltiazem Hcl	11	suppressed
Epinephrine	Epinephrine	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error